DDAVP Infusion Does Not Affect Plasma Levels of Endothelin-1 in Four Normal Subjects

Thromb Haemost 1992; 68(05): 621
DOI: 10.1055/s-0038-1646329

Letter to the Editor

Schattauer GmbH Stuttgart

Bianca Marasini

Institute of Internal Medicine, University of Milan, Italy

,

Massimo Cugno

Institute of Internal Medicine, University of Milan, Italy

,

Cristina Bassani

Institute of Internal Medicine, University of Milan, Italy

,

Irene Fabrizi

Institute of Internal Medicine, University of Milan, Italy

,

Bianca Bottasso

^*Hemophilia and Thrombosis Center, University of Milan, Italy

,

Angelo Agostoni

Institute of Internal Medicine, University of Milan, Italy

REFERENCES
1 Mannucci PM. Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders. Blood 1988; 72: 1449-1455
2 Levi M, ten Cate JW, Dooijeward G, Sturk A, Brommer EJP, Agnelli G. DDAVP induces systemic release of urokinase-type plasminogen activator. Thromb Haemostas 1989; 62: 686-689
3 Letowska M, Bykowska K, Sablinski J, Lopaciuk S, Kopec M. Venostasis but not DDAVP infusion provokes the plasma fibronectin increase. Thromb Haemostas 1990; 64: 294-296
4 Takahashi H, Tatewaki W, Wada K, Niwano H, Hanano M, Tsubouchi J, Nagai T, Shibata A. DDAVP does not induce the release of thrombomodulin from endothelial cells. Thromb Haemostas 1991; 65: 451
5 Wagner OF, Nowotny P, Vierhapper H. Unchanged plasma concentrations of endothelin-1 in healthy men during short term infusion of AMP, dDAVP and norepinephrine. Horm Metab Res 1991; 23: 191-192
6 Cernacek P, Stewart DJ. Immunoreactive endothelin in human plasma: marked elevations in patients in cardiogenic shock. Biochem Biophys Res Common 1989; 161: 562-567
7 Biondi ML, Marasini B, Bassani C, Agostoni A. Increased plasma endothelin levels in patients with Raynaud's phenomenon. N Engl J Med 1991; 324: 1139-1140